Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Jonathan E. Rosenberg"'
Autor:
Min Yuen Teo, Brendan J. Guercio, Arshi Arora, Xueli Hao, Ashley M. Regazzi, Timothy Donahue, Harry W. Herr, Alvin C. Goh, Eugene K. Cha, Eugene Pietzak, Sherri M. Donat, Guido Dalbagni, Bernard H. Bochner, Semra Olgac, Judy Sarungbam, S. Joseph Sirintrapun, Ying-Bei Chen, Anuradha Gopalan, Samson W. Fine, Satish K. Tickoo, Victor E. Reuter, Britta Weigelt, Anne M. Schultheis, Samuel A. Funt, Dean F. Bajorin, David B. Solit, Gopa Iyer, Irina Ostrovnaya, Jonathan E. Rosenberg, Hikmat Al-Ahmadie
Publikováno v:
Clin Genitourin Cancer
INTRODUCTION: Small cell carcinoma of the bladder (SCCB) is a rare variant of bladder cancer with poor outcomes. We evaluated long-term outcomes of nonmetastatic (M0) and metastatic (M1) SCCB and correlated pathologic response with genomic alteration
Autor:
Joshua J. Meeks, Peter C. Black, Matthew Galsky, Petros Grivas, Noah M. Hahn, Syed A. Hussain, Matthew I. Milowsky, Gary D. Steinberg, Robert S. Svatek, Jonathan E. Rosenberg
Publikováno v:
European Urology.
Autor:
Daniel P. Petrylak, Cindy Xu, Corina Andresen, Ulka N. Vaishampayan, Jessica Rearden, Howard A. Burris, Jean H. Hoffman-Censits, Ugo De Giorgi, Sumanta K. Pal, Sumati Gupta, Jonathan E. Rosenberg, Dean F. Bajorin, Yung Lyou, Ai Li, Siamak Daneshmand, David I. Quinn, Petros Grivas, Susan Moran, Matthew D. Galsky
Publikováno v:
Clinical Genitourinary Cancer. 20:35-42
Introduction To describe the efficacy of infigratinib, a potent, selective fibroblast growth factor receptor (FGFR) 1-3 tyrosine kinase inhibitor, across lines of therapy (LOT) in patients with metastatic urothelial cancer (mUC). Patients and Methods
Autor:
Darren R. Feldman, Martin H. Voss, Ashley Marie Regazzi, Dana E. Rathkopf, Robert J. Motzer, Michael J. Morris, Gopa Iyer, Jonathan E. Rosenberg, Michal Sarfaty, Dean F. Bajorin
Publikováno v:
Clinical Genitourinary Cancer
Background The worldwide COVID-19 public health pandemic has restructured clinical care of cancer patients throughout the world. The specific changes in the management of genitourinary (GU) cancers in different cancer centers due to COVID-19 are not
Autor:
Dean F. Bajorin, Samuel A. Funt, Min Yuen Teo, Guido Dalbagni, David B. Solit, Eugene J. Pietzak, Jose Mauricio Mota, Hikmat Al-Ahmadie, Chung-Han Lee, Karissa Whiting, Han A. Li, Bernard H. Bochner, Gopa Iyer, Jonathan E. Rosenberg, Arjun Vasant Balar, Matthew I. Milowsky, Irina Ostrovnaya
Publikováno v:
European Urology. 78:907-915
Background Alterations in fibroblast growth factor receptor 3 (FGFR3) occur in ∼15% of muscle-invasive bladder cancers (MIBCs) and metastatic urothelial carcinomas (mUCs). Objective To determine the association between FGFR3 status and response to
Autor:
Mahrukh A. Huseni, Lifen Wang, Joanna E. Klementowicz, Kobe Yuen, Beatrice Breart, Christine Orr, Li-fen Liu, Yijin Li, Vinita Gupta, Congfen Li, Deepali Rishipathak, Jing Peng, Yasin Şenbabaoǧlu, Zora Modrusan, Shilpa Keerthivasan, Shravan Madireddi, Ying-Jiun Chen, Eleanor J. Fraser, Ning Leng, Habib Hamidi, Hartmut Koeppen, James Ziai, Kenji Hashimoto, Marcella Fassò, Patrick Williams, David F. McDermott, Jonathan E. Rosenberg, Thomas Powles, Leisha A. Emens, Priti S. Hegde, Ira Mellman, Shannon J. Turley, Mark S. Wilson, Sanjeev Mariathasan, Luciana Molinero, Mark Merchant, Nathaniel R. West
Publikováno v:
Cell Reports Medicine. 4:100878
Autor:
Timothy N. Clinton, Ziyu Chen, Hannah Wise, Andrew T. Lenis, Shweta Chavan, Mark TA Donoghue, Nima Almassi, Shawn Dason, Pavitra Rao, James Rodrigues, Naresh Vasani, Fourat Ridouani, Jonathan E. Rosenberg, Dean F. Bajorin, Min Yuen Teo, Bernard H. Bochner, Michael Berger, Irina Ostrovnaya, Eugene J. Pietzak, Gopa Iyer, Sizhi Paul Gao, Wenhuo Hu, Hikmat A. Al-Ahmadie, David B. Solit
Publikováno v:
SSRN Electronic Journal.
Autor:
Jonathan A. Coleman, Esther Drill, Irina Ostrovnaya, Maria E. Arcila, Gopa Iyer, Dean F. Bajorin, Eugene J. Pietzak, Gowtham Jayakumaran, Jonathan E. Rosenberg, Hikmat Al-Ahmadie, Sumit Isharwal, David B. Solit, Bernard H. Bochner, Timothy R. Donahue, François Audenet, Eugene K. Cha, Victor E. Reuter, Guido Dalbagni, Michael F. Berger
Publikováno v:
European Urology Focus. 5:201-204
Point mutations in the TERT gene promoter occur at high frequency in multiple cancers, including urothelial carcinoma (UC). However, the relationship between TERT promoter mutations and UC patient outcomes is unclear due to conflicting reports in the
Autor:
M.S. van der Heijden, Daniel Castellano, Nobuaki Matsubara, Howard Gurney, Thomas Powles, Guru Sonpavde, Jens Bedke, H. Pappo, Jonathan E. Rosenberg, Ronac Mamtani, B. Valderram, Ignacio Duran, Srikala S. Sridhar, Daniel P. Petrylak, J.-L. Lee, Christof Vulsteke, Y. Loriot, Zsolt Hepp, M. Vuillet
Publikováno v:
Progrès en Urologie. 31:813-814
Autor:
Ronac Mamtani, Daniel P. Petrylak, J.-L. Lee, Christof Vulsteke, Helle Pappot, Thomas Powles, Jens Bedke, Srikala S. Sridhar, Guru Sonpavde, Jonathan E. Rosenberg, M.S. van der Heijden, Howard Gurney, Chunzhang Wu, Matthew T. Campbell, Maria Matsangou, Nobuaki Matsubara, Daniel Castellano, Yohann Loriot, Ignacio Duran
Publikováno v:
Annals of Oncology. 32:S710-S711